This is a Pfizer news story, published by Yahoo, that relates primarily to Novavax news.
For more Pfizer news, you can click here:
more Pfizer newsFor more Novavax news, you can click here:
more Novavax newsFor more vaccine development news, you can click here:
more vaccine development newsFor more news from Yahoo, you can click here:
more news from YahooOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like this article about vaccine development, you might also like this article about
new vaccine. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest annual vaccines news, COVID vaccines news, news about vaccine development, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
previous vaccineABC News
•88% Informative
Updated COVID-19 vaccines will target the JN.1 lineage of the virus, an offshoot of the omicron variant.
Updated vaccines from Pfizer , Moderna and Novavax will be available in either August or September .
CDC recommends everyone ages 6 months and older receive an updated vaccine.
VR Score
90
Informative language
88
Neutral language
85
Article tone
semi-formal
Language
English
Language complexity
54
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
10
Source diversity
3
Affiliate links
no affiliate links